• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD38:T 细胞免疫代谢调节剂。

CD38: T Cell Immuno-Metabolic Modulator.

机构信息

Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.

Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

Cells. 2020 Jul 17;9(7):1716. doi: 10.3390/cells9071716.

DOI:10.3390/cells9071716
PMID:32709019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7408359/
Abstract

Activation and subsequent differentiation of T cells following antigenic stimulation are triggered by highly coordinated signaling events that lead to instilling cells with a discrete metabolic and transcriptional feature. Compelling studies indicate that intracellular nicotinamide adenine dinucleotide (NAD) levels have profound influence on diverse signaling and metabolic pathways of T cells, and hence dictate their functional fate. CD38, a major mammalian NAD glycohydrolase (NADase), expresses on T cells following activation and appears to be an essential modulator of intracellular NAD levels. The enzymatic activity of CD38 in the process of generating the second messenger cADPR utilizes intracellular NAD and thus limits its availability to different NAD consuming enzymes (PARP, ART, and sirtuins) inside the cells. The present review discusses how the CD38-NAD axis affects T cell activation and differentiation through interfering with their signaling and metabolic processes. We also describe the pivotal role of the CD38-NAD axis in influencing the chromatin remodeling and rewiring T cell response. Overall, this review emphasizes the crucial contribution of the CD38NAD axis in altering T cell response in various pathophysiological conditions.

摘要

抗原刺激后 T 细胞的激活和随后的分化是由高度协调的信号事件触发的,这些信号事件使细胞获得离散的代谢和转录特征。有说服力的研究表明,细胞内烟酰胺腺嘌呤二核苷酸(NAD)水平对 T 细胞的多种信号和代谢途径有深远影响,因此决定了它们的功能命运。CD38 是一种主要的哺乳动物 NAD 糖水解酶(NADase),在 T 细胞激活后表达,并似乎是细胞内 NAD 水平的重要调节剂。CD38 在生成第二信使 cADPR 的过程中的酶活性利用细胞内 NAD,从而限制其在细胞内不同的 NAD 消耗酶(PARP、ART 和 sirtuins)中的可用性。本综述讨论了 CD38-NAD 轴如何通过干扰 T 细胞的信号和代谢过程来影响 T 细胞的激活和分化。我们还描述了 CD38-NAD 轴在影响染色质重塑和重新布线 T 细胞反应中的关键作用。总的来说,本综述强调了 CD38-NAD 轴在改变各种病理生理条件下 T 细胞反应中的重要贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a18/7408359/ab85357f4ec6/cells-09-01716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a18/7408359/1fc0381df9ee/cells-09-01716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a18/7408359/ab85357f4ec6/cells-09-01716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a18/7408359/1fc0381df9ee/cells-09-01716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a18/7408359/ab85357f4ec6/cells-09-01716-g002.jpg

相似文献

1
CD38: T Cell Immuno-Metabolic Modulator.CD38:T 细胞免疫代谢调节剂。
Cells. 2020 Jul 17;9(7):1716. doi: 10.3390/cells9071716.
2
Regulation of intracellular levels of NAD: a novel role for CD38.细胞内烟酰胺腺嘌呤二核苷酸(NAD)水平的调节:CD38的新作用
Biochem Biophys Res Commun. 2006 Jul 14;345(4):1386-92. doi: 10.1016/j.bbrc.2006.05.042. Epub 2006 May 15.
3
CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.CD38作为细胞烟酰胺腺嘌呤二核苷酸(NAD)的调节因子:代谢性疾病的新型潜在药理学靶点
Curr Pharm Des. 2009;15(1):57-63. doi: 10.2174/138161209787185788.
4
Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen.海兔ADP-核糖基环化酶的酶学性质:与CD38抗原的NAD糖水解酶的比较。
J Biochem. 1995 Jan;117(1):125-31. doi: 10.1093/oxfordjournals.jbchem.a124698.
5
Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.cADP-核糖-CD38复合物作为CD38/NAD⁺糖水解酶催化反应中间体的动力学活性:对CD38信号传导的影响
Biochem J. 2001 Sep 1;358(Pt 2):399-406. doi: 10.1042/0264-6021:3580399.
6
Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38.ADP核糖基环化酶和CD38将烟酰胺腺嘌呤二核苷酸(NAD)环化为环磷酸腺苷核糖(cADPR)的机制。
J Biol Chem. 2009 Oct 2;284(40):27629-36. doi: 10.1074/jbc.M109.030965. Epub 2009 Jul 28.
7
CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins.CD38调控T细胞表面蛋白的ADP-核糖基转移酶-2催化的ADP-核糖基化。
J Immunol. 2005 Mar 15;174(6):3298-305. doi: 10.4049/jimmunol.174.6.3298.
8
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.CD38 糖基水解酶和 NAD 汇:对病理状况的影响。
Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C521-C545. doi: 10.1152/ajpcell.00451.2021. Epub 2022 Feb 9.
9
Ectocellular CD38-catalyzed synthesis and intracellular Ca2+-signalling activity of cyclic ADP-ribose in T-lymphocytes are not functionally related.细胞外CD38催化的T淋巴细胞中环磷酸腺苷核糖的合成与细胞内Ca2+信号传导活性在功能上不相关。
FEBS Lett. 1998 Nov 20;439(3):291-6. doi: 10.1016/s0014-5793(98)01396-9.
10
CD38: An important regulator of T cell function.CD38:T 细胞功能的重要调节因子。
Biomed Pharmacother. 2022 Sep;153:113395. doi: 10.1016/j.biopha.2022.113395. Epub 2022 Jul 11.

引用本文的文献

1
Granulocyte-Macrophage Colony-Stimulating Factor Inhibition Ameliorates Innate Immune Cell Activation, Inflammation, and Salt-Sensitive Hypertension.粒细胞-巨噬细胞集落刺激因子抑制可改善先天性免疫细胞活化、炎症和盐敏感性高血压。
Cells. 2025 Jul 24;14(15):1144. doi: 10.3390/cells14151144.
2
NAD + metabolism and function in innate and adaptive immune cells.NAD+在先天性和适应性免疫细胞中的代谢与功能。
J Inflamm (Lond). 2025 Aug 1;22(1):30. doi: 10.1186/s12950-025-00457-7.
3
Novel loop structure of human IgG1 Fc fused CD38 targeted bispecific antibodies and their anti-tumor effect in acute myeloid leukemia.

本文引用的文献

1
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.患者康复前伴随免疫反应的广度:非重症COVID-19病例报告
Nat Med. 2020 Apr;26(4):453-455. doi: 10.1038/s41591-020-0819-2.
2
The taming of PARP1 and its impact on NAD metabolism.PARP1 的抑制及其对 NAD 代谢的影响。
Mol Metab. 2020 Aug;38:100950. doi: 10.1016/j.molmet.2020.01.014. Epub 2020 Feb 12.
3
EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis.EZH2 缺失可减弱类风湿关节炎中 Treg 的分化。
人IgG1 Fc融合CD38靶向双特异性抗体的新型环结构及其在急性髓系白血病中的抗肿瘤作用。
J Transl Med. 2025 Jul 28;23(1):849. doi: 10.1186/s12967-025-06827-2.
4
Inhibition of CD38 by 78c Enhanced NAD, Alleviated Inflammation, and Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens.78c对CD38的抑制增强了老年小鼠巨噬细胞中由口腔病原体诱导的NAD水平,减轻了炎症并降低了氧化应激。
Int J Mol Sci. 2025 Jun 26;26(13):6180. doi: 10.3390/ijms26136180.
5
Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure.与年龄相关的烟酰胺腺嘌呤二核苷酸水平下降导致嵌合抗原受体T细胞(CAR-T)功能衰竭。
Nat Cancer. 2025 May 20. doi: 10.1038/s43018-025-00982-7.
6
CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor.CD38介导的代谢重编程促进肿瘤中调节性T细胞的稳定性和抑制功能。
Sci Adv. 2025 Mar 21;11(12):eadt2117. doi: 10.1126/sciadv.adt2117.
7
Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course.肌萎缩侧索硬化症病程中调节性T细胞水平及表型改变
Front Immunol. 2025 Jan 8;15:1508974. doi: 10.3389/fimmu.2024.1508974. eCollection 2024.
8
TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC.肿瘤溶解综合征与免疫细胞分析:免疫化疗对可切除Ⅲ期非小细胞肺癌肿瘤微环境的免疫调节作用
Front Immunol. 2024 Dec 11;15:1499731. doi: 10.3389/fimmu.2024.1499731. eCollection 2024.
9
CD38 Inhibitor 78c Attenuates Pro-Inflammatory Cytokine Expression and Osteoclastogenesis in Macrophages.CD38抑制剂78c可减轻巨噬细胞中促炎细胞因子的表达和破骨细胞生成。
Cells. 2024 Nov 28;13(23):1971. doi: 10.3390/cells13231971.
10
Integrated Multi-Omics Analysis of Cerebrospinal Fluid in Postoperative Delirium.术后谵妄患者脑脊液的综合多组学分析。
Biomolecules. 2024 Jul 30;14(8):924. doi: 10.3390/biom14080924.
J Autoimmun. 2020 Mar;108:102404. doi: 10.1016/j.jaut.2020.102404. Epub 2020 Jan 15.
4
The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections.CD38/NAD/SIRTUIN1/EZH2 轴减轻细胞毒性 CD8+T 细胞功能,并鉴定出易患 SLE 感染的患者。
Cell Rep. 2020 Jan 7;30(1):112-123.e4. doi: 10.1016/j.celrep.2019.12.014.
5
The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors.CD38 在实体瘤代谢微环境和免疫细胞功能中的好坏与未知之处。
Cells. 2019 Dec 24;9(1):52. doi: 10.3390/cells9010052.
6
Foxp3 Post-translational Modifications and Treg Suppressive Activity.Foxp3 的翻译为“叉头框蛋白 P3”,Post-translational Modifications 翻译为“翻译后修饰”,Treg 是“调节性 T 细胞”的缩写,所以整句话可以译为:叉头框蛋白 P3 的翻译后修饰与调节性 T 细胞的抑制活性。
Front Immunol. 2019 Oct 18;10:2486. doi: 10.3389/fimmu.2019.02486. eCollection 2019.
7
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity.促生存脂质神经酰胺 1-磷酸通过代谢将 T 细胞编程以限制抗肿瘤活性。
Cell Rep. 2019 Aug 13;28(7):1879-1893.e7. doi: 10.1016/j.celrep.2019.07.044.
8
The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases.多功能细胞外酶 CD38:在免疫调节、癌症、衰老和代谢疾病中的作用。
Front Immunol. 2019 May 31;10:1187. doi: 10.3389/fimmu.2019.01187. eCollection 2019.
9
SIRT1 regulates metabolism and leukemogenic potential in CML stem cells.SIRT1 调节 CML 干细胞的代谢和白血病发生潜能。
J Clin Invest. 2019 Jun 10;129(7):2685-2701. doi: 10.1172/JCI127080.
10
Transcriptional and Epigenetic Regulation of Effector and Memory CD8 T Cell Differentiation.效应器和记忆 CD8 T 细胞分化的转录和表观遗传调控。
Front Immunol. 2018 Dec 7;9:2826. doi: 10.3389/fimmu.2018.02826. eCollection 2018.